Company Analysis Edwards Lifesciences Corporation
1. Summary
Advantages
- Current debt level 6.64% is below 100% and has decreased over 5 years from 10.46%.
- The company's current efficiency (ROE=21.09%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (68.51 $) is higher than fair price (28.44 $)
- Dividends (0%) are below the sector average (1.31%).
- The stock's return over the last year (-26.28%) is lower than the sector average (-18.38%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 17:15 Medical-device makers gain amid return to normalcy
2.3. Market efficiency
| Edwards Lifesciences Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -4.6% | -13.3% | 0.5% |
| 90 days | -7.4% | -13% | -5.3% |
| 1 year | -26.3% | -18.4% | 8.7% |
EW vs Sector: Edwards Lifesciences Corporation has significantly underperformed the "Healthcare" sector by -7.9% over the past year.
EW vs Market: Edwards Lifesciences Corporation has significantly underperformed the market by -34.99% over the past year.
Stable price: EW is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EW with weekly volatility of -0.5053% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (68.51 $) is higher than the fair price (28.44 $).
Price is higher than fair: The current price (68.51 $) is 58.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (32.95) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (32.95) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.88) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (6.88) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.7) is higher than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (7.7) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (29.83) is higher than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (29.83) is higher than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.06% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.06%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (21.09%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (21.09%) is lower than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (14.98%) is higher than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (14.98%) is higher than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (25.64%) is higher than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (25.64%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (12.11%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
